Price list of medical services for foreign citizens

1.

Determination of hormones and tumor markers by EIA

1.1.

Determination of anti-thyroid peroxidase antibodies concentration (Anti-TPO)

24,34

1.2.

Determination of free thyroxine (T4 free) concentration

25,38

1.3.

Determination of thyrotropin (TSH) concentration

23,88

2.

Immunological tests

2.4.

Determination of reactive oxygen production by blood neutrophils

16,00

2.5.

Determination of the main subpopulations of blood mononuclear cells (T- and B-lymphocytes, NK cells, T-helpers, T-cytotoxic, activated lymphocytes)

55,00

2.6.

Determination of the main and additional subpopulations of blood mononuclear cells (T- and B-lymphocytes, NK cells, T-helpers, T-cytotoxic, activated lymphocytes)

92,00

2.7.

Determination of blood T-cell subpopulations (naive T-cells, central memory T-cells, preterminally differentiated T-cells, terminally differentiated T-cells)

37,00

3.

Diagnosis of parasitic diseases

3.1.

Test on the intestinal group of parasitic diseases (ascariasis, difilllobothriasis, trichuriasis, opisthorchiasis, clonorchiasis, blastocytosis). Sorption method.

38,22

3.2.

Test on the intestinal group of parasitic diseases (hymenolepiasis, diphyllobothriasis, schistosomiasis, nanophyetosis, metagonimiasis, etc.). Precipitation method.

37,04

3.3.

Coprogram

9,85

3.4.

Determination of helminth eggs by the Kato method

3,01

3.5.

Detection of class IgG antibodies to toxocar antigens by EIA

19,14

3.6.

Detection of class IgM antibodies to opisthorchis antigens by EIA

19,27

3.7.

Detection of class IgG antibodies to opisthorchis antigens by EIA

19,27

3.8.

Detection of class IgM antibodies to trichinella antigens by EIA

20,11

3.9.

Detection of class IgG antibodies to trichinella antigens by EIA

20,11

3.10.

Detection of class IgG antibodies to echinococcus antigens by EIA

20,32

3.11.

Detection of classes IgA, IgM, and IgG antibodies to Giardia antigens by EIA

19,69

3.12.

Detection of class IgM antibodies to lamblia antigens by EIA

20,07

3.13.

Detection of class IgG antibodies to Ascaris lumbricoides antigens by EIA

22,71

4.

Diagnosis of tick-borne infections

4.2.

Detection of antigen of pathogen of Lyme borreliosis in ticks by IIFR

12,07

4.4.

Detection of classes IgM and IgG antibodies to pathogen of Lyme borreliosis by IIFR

32,29

4.5.

Detection of class IgM antibodies to pathogen of Lyme borreliosis by IIFR

26,03

4.6.

Detection of class IgG antibodies to pathogen of Lyme borreliosis by IIFR

25,84

4.7.

Detection of class IgG antibodies to pathogen of Lyme borreliosis by EIA

20,66

4.8.

Detection of class IgM antibodies to tick-borne encephalitis virus by EIA

18,85

4.9.

Detection of class IgG antibodies to tick-borne encephalitis virus by EIA

18,85

4.10.

Detection of class IgM antibodies to pathogen of Lyme borreliosis by EIA

20,66

4.11.

Identification of RNA/DNA of pathogens transmitted by ixodid ticks (tick-borne encephalitis virus, Lyme disease, anaplasmosis, ehrlichiosis) by PCR

63,55

5.

Diagnosis of intestinal infections

5.1.

Identification of DNA of pathogen of yerseniasis (Y. pseudotuberculosis and Y. enterocolitica) by real-time PCR

33,80

5.7.

Determination of RNA pathogens of acute intestinal viral infections by PCR:

Noro/rota/adeno/entero

58,16

5.8.

Enterovirus antigen detection by EIA

23,54

5.9.

Detection of class IgM antibodies to enteroviruses by EIA

19,37

5.11.

Test of human stool material for the quantitative determination of calprotectin by EIA

48,99

6.

Diagnosis of gastrointestinal diseases

6.2.

Detection of total antibodies to CagA antigen Helicobacter pylori by EIA

20,74

7.

Diagnosis of vaccine preventable infections

7.1.

Determination of antibodies to poliovirus types 1, 2, and 3 in NT in cell culture

46,65

7.2.

Detection of class IgM antibodies to parvovirus В19 by EIA

15,47

7.3.

Detection of class IgG antibodies to parvovirus В19 by EIA

13,26

7.4.

Detection of parvovirus В19 DNA by real-time PCR

13,07

7.5.

Detection of class IgM antibodies to chickenpox virus by EIA

12,70

7.6.

Detection of class IgG antibodies to chickenpox virus by EIA

11,30

7.7.

Detection of class IgM antibodies to mumps virus by EIA

15,95

7.8.

Detection of class IgG antibodies to mumps virus by EIA

14,85

7.9.

Detection of class IgG antibodies to к вирусу краснухи by EIA

13,13

7.10.

Detection of class IgM antibodies to к вирусу краснухи by EIA

14,77

7.11.

Выявление возбудителя коклюша by PCR 

16,50

7.12.

Detection of mumps virus RNA by RT-PCR

17,54

7.13.

Identification of Corynebacterium diphtheriae by PCR 

18,60

7.14.

Detection of measles virus RNA by real-time RT-PCR

25,27

7.15.

Detection of measles virus by PCR 

25,27

7.16.

Detection of class IgM antibodies to measles virus by EIA

15,63

7.17.

Detection of class IgG antibodies to measles virus by EIA

13,66

7.18.

Detection of class IgG antibodies to pertussis toxin by EIA

14,86

7.19.

Detection of class IgG antibodies to diphtheria toxin by EIA

20,75

7.20.

Detection of class IgG antibodies to tetanus toxoid by EIA

19,41

8.

Diagnosis of respiratory infections

8.1.

Detection of class IgM antibodies to Mycoplasma pneumonia by EIA

20,32

8.2.

Detection of class IgG antibodies to Mycoplasma pneumonia by EIA

20,32

8.3.

Detection of class IgG antibodies to Chlamydia pneumonia by EIA

20,32

8.4.

Detection of class IgM antibodies to Chlamydia pneumonia by EIA

20,32

9.

Diagnosis of polyomavirus

9.1.

Quantitation determination of polyomaviruses by PCR (BKV or JCV test)

36,64

9.2.

Qualitative detection of polyomaviruses by PCR (BKV or JCV test)

33,10

10.

Diagnosis of chlamydiosis

10.1.

Isolation of chlamydia (Ch. trachomatis) in cell culture with a cytopathic effect

90,82

10.2.

Isolation of chlamydia (Ch. trachomatis) in cell culture with a cytopathic effect, with determination of sensitivity to 6 antibiotics

151,00

10.3.

Detection of chlamydia (Ch. trachomatis) by IFR

23,47

10.5.

Determination of immunoglobulins of one class to Chlamydia trachomatis with manual calculation of the positivity coefficient and antibody titer

4,61

10.6.

Detection of Chlamydia trachomatis DNA by PCR

18,24

10.7.

Chlamydia detection using fluorescently labeled immunomagnetic nanoparticles

29,94

11.

Diagnosis of toxoplasmosis

11.1.

Detection of class IgG antibodies to Toxoplasma gondii by EIA

23,27

11.2.

Detection of class IgA antibodies to Toxoplasma gondii by EIA

19,80

11.3.

Detection of class IgM antibodies to Toxoplasma gondii by EIA

18,22

12.

Diagnosis of sexually transmitted infections

12.1.

Isolation of Trichomonas by seeding on cell culture

90,22

12.2.

Cultural study for ureaplasmas and mycoplasmas, semi-quantitative titer assessment and determination of sensitivity to antibiotics

33,52

12.3.

Detection of ureaplasma DNA (U. urealyticum, U. parvum) by PCR

18,44

12.5.

Detection of Trichomonas vaginalis DNA by PCR

18,76

12.6.

Detection of Gardnerella vaginalis DNA by PCR

18,44

12.7.

Microscopic examination of genitourinary organs discharge (from urethra, cervical canal, vagina, prostate secretion)

16,47

12.12.

Detection of Chlamydia trachomatis antigens by IFR

23,34

12.13.

Detection of Ureaplasma urealyticim antigens by IFR

23,55

12.14.

Detection of cytomegalovirus antigens by IIFR

27,84

13.

Diagnosis of papillomavirus infection

13.1.

Detection of DNA of human papillomavirus types 16 and 18 by PCR

19,23

13.2.

Quantitative detection of DNA of 21 types of human papillomavirus with PCR typing, HPV quantum 21

57,08

14.

Diagnosis of a herpetic infection

14.1.

Isolation of herpes virus type 1 and 2, cytomegalovirus in cell culture

97,96

14.2.

Detection of herpes virus 1, 2 types by IIFR

12,55

14.3.

Detection of class IgG antibodies to herpes virus 6 type by EIA

22,25

14.4.

Detection of class IgM antibodies to herpes simplex virus 1 and 2 types by EIA

18,22

14.5.

Detection of class IgG antibodies to herpes simplex virus 1 and 2 types by EIA

17,80

14.6.

Detection of class IgM antibodies to cytomegalovirus by EIA

18,22

14.7.

Detection of class IgG antibodies to cytomegalovirus by EIA

19,80

14.8.

Detection of class IgG antibodies to nuclear antigen NA of Epstein-Barr virus by EIA

20,28

14.9.

Detection of class IgM antibodies to capsid antigen VCA of Epstein-Barr virus by EIA

20,61

14.10.

Detection of class IgG antibodies to early EA antigens of Epstein-Barr virus by EIA

20,28

14.11.

Detection of herpes virus type 6 DNA by PCR

19,16

14.12.

Detection of cytomegalovirus DNA by PCR

18,55

14.13.

Detection of Epstein-Barr virus DNA by PCR

26,30

14.14.

Detection of DNA of herpes simplex virus 1 and 2 types by PCR

18,19

15.

HIV diagnosis

15.1.

Determination of HIV subtype and mutations of resistance to antiretroviral drugs

132,62

15.2.

Determination of HIV subtype and phylogenetic relationships

141,22

15.3.

Quantitative determination of HIV RNA by PCR

37,47

16.

Diagnosis of hepatitis B

16.1.

Determination of the subtype and mutations of resistance to analogues of nucleotides of the hepatitis B virus by sequencing

93,63

16.2.

Determination of the subtype or mutations of resistance to analogues of nucleotides of the hepatitis B virus by sequencing

93,63

16.3.

Quantitative determination of hepatitis B virus DNA

26,38

16.4.

Hepatitis B marker detection (HBsAg) by EIA

15,70

16.5.

Hepatitis B marker detection (HBsAg) by EIA and a confirmatory test

37,93

16.6.

Confirmatory test to presence of HBsAg of the hepatitis B virus

22,23

17.

Diagnosis of hepatitis C

17.1.

Determination of the subtype of hepatitis C virus by sequencing

94,41

17.2.

Determination of the polymorphism of IL28B gene in the regions rs12979860 and rs8099917 by sequencing

90,30

17.3.

Detection of markers of hepatitis C (class IgM and IgG antibodies) by EIA

12,72

17.4.

Highly sensitive quantification of hepatitis C virus RNA by enrichment PCR

52,07

17.5.

Quantitative determination of hepatitis C virus RNA by PCR

38,36

17.6.

Confirmatory test to presence of class IgG and IgM antibodies to the hepatitis C virus

26,40

17.7.

Detection of markers of hepatitis C (class IgM and IgG antibodies) and a confirmatory test by EIA

39,12

18.

Diagnosis of COVID19

18.1.

Detection of SARS-CoV-2 virus nucleocapsid antigen by express immunochromatographic analysis in a swab from the oropharynx and nasopharynx

26,94

18.2.

Test of nasopharyngeal swabs for Covid-19 by PCR

43,00

Determination of antibodies to viral and bacterial agents by enzyme immunoassay with semi-automated calculation

18.3.

Detection of total antibodies to SARS-CoV-2 coronavirus (single test)

50,78

18.4.

Detection of total antibodies to SARS-CoV-2 coronavirus (one test in a series)

23,48

18.5.

Detection of class IgM antibodies to SARS-CoV-2 coronavirus (single test)

48,23

18.6.

Detection of class IgM antibodies to SARS-CoV-2 coronavirus (one test in a series)

22,52

18.7.

Detection of class IgG antibodies to SARS-CoV-2 coronavirus (single test)

48,29

18.8.

Detection of class IgG antibodies to SARS-CoV-2 coronavirus (one test in a series)

22,54

18.9.

Detection of class IgG antibodies to SARS-CoV-2 coronavirus after immunization with Sputnik V vaccine

37,50

18.10.

QR code design

6,00

18.11.

Quantitative determination of class IgG antibodies to SARS-CoV-2 coronavirus S-protein (single test)

60,00

18.12.

Quantitative determination of class IgG antibodies to SARS-CoV-2 coronavirus S-protein (one test in a series)

28,00

19.

Individual services

19.1.

Registration (preliminary and final) of the material, patient passport data, and test results in journals and forms

1,23

19.2.

Reception, preliminary registration of plasma or serum samples, or other ready-made biomaterials, accounting for the results issuance in centralized laboratories

0,20

19.3.

Pipetting with glass pipettes

1,04

19.4.

Pipetting with semi-automatic pipettes

0,32

19.5.

Treatment of venous blood to obtain plasma or serum

0,33

19.6.

Finger blood sampling

2,23

19.7.

Blood sampling from a vein

4,01

19.8.

Blood sampling from a vein for antibodies to SARS CoV-2

4,87

19.9.

Taking a smear for test

2,19

19.10.

Taking a nasopharyngeal swab for Covid 19

3,19

19.11.

Sampling of bacteriological material from patients into the transport medium (from discharge of nose, pharynx, skin foci of inflammation, eyes), each separately

3,38

19.12.

Sampling of bacteriological material from patients (from discharge of nose, pharynx, skin foci of inflammation, eyes), each separately

2,00

19.13.

Preparation of transport medium with mucolytic for PCR

1,14

19.14.

Biological material sampling

3,19

19.15.

Taking gynecological smear for bacterial culture (women)

3,94

19.16.

Taking urological smear for bacterial culture (men)

2,59

19.17.

Taking gynecological smear (women)

3,56

19.18.

Taking urological smear (men)

1,95

20.

Electron microscopy

20.1.

Sample preparation and its electron microscope examination

250,33

20.2.

Electron microscopic analysis of ultrathin sections

102,36

21.

Diagnostic bacteriological examination

21.1.

Bacteriological examination of sputum and bronchial washings for aerobic and facultative microorganisms

28,81

21.2.

Bacteriological examination of urine for aerobic and facultative microorganisms

23,10

21.3.

Bacteriological examination of pus, wound discharge, infiltrates, abscesses, transudates, exudates for aerobic and facultative microorganisms

28,51

21.4.

Bacteriological examination of the discharge of the genital organs

30,59

21.5.

Bacteriological examination of detachable eyes for anaerobic and facultative anaerobic microorganisms

26,16

21.6.

Bacteriological examination of the discharge of the nasopharynx, nose, ear for anaerobic and facultative anaerobic microorganisms

21,72

21.7.

Bacteriological examination of breast milk anaerobic and facultative anaerobic microorganisms

16,97

21.8.

Bacteriological examination for diphtheria of the detachable pharynx and nose

11,05

21.9.

Bacteriological examination of feces for pathogenic intestinal flora

16,89

21.10.

Bacteriological study of intestinal microbiocinosis (dysbacteriosis)

50,35

21.11.

Bacteriological examination of feces for pathogenic intestinal flora with serodiagnosis

55,69

22.

Molecular biological research

22.1.

Primary processing of other biological material

6,00

22.2.

Isolation of RNA/DNA from other biological material (sorbent method) (single)

16,30

22.3.

Isolation of RNA/DNA from other biological material (sorbent method) (serial)

8,20

22.4.

Real-time PCR with detection by endpoint for qualitative DNA/RNA detection (single)

14,00

22.5.

Real-time PCR with detection by endpoint for qualitative DNA/RNA detection (serial)

10,40